Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Devastated by the loss of her husband Kenneth Bruntel to pancreatic cancer, Gail Coleman is laser-focused on funding research offering hope and...
The Lustgarten Foundation and the American Association for Cancer Research (AACR) have established two new career development awards for both...
So far, 2020 has proved to be incredibly challenging for so many of us. The Lustgarten Foundation—the largest private funder of pancreatic cancer...
Several thousand participants hit the streets throughout the New York metropolitan area in support of the Lustgarten Foundation a year ago. Times...
On Sunday, July 14th, walk leader Ann Zediker will again lead the annual Lustgarten Foundation Pancreatic Cancer Research Walk in Naperville,...
The Lustgarten Foundation announced today the appointment of Elizabeth M. Jaffee, M.D., the immediate past president of the American Association for...
Pancreatic cancer has shown to have limited effective treatment strategies. Researchers in the Lustgarten Foundation Pancreatic Cancer Research...
The Lustgarten Foundation is pleased to announce two new pancreatic cancer research laboratories through respective partnerships with Dana-Farber...
In a study published in Nature, researchers found that the breakdown of muscle tissue and adipose (fat) is an early sign of pancreatic cancer. The...
In a study published today in Cancer Discovery, genomic analyses of metastatic pancreatic cancers have suggested that approximately one third of...
Today in Cancer Discovery, an international team of researchers led by Dr. David Tuveson, Cold Spring Harbor Laboratory (CSHL) Professor and Chief...
Lustgarten Foundation Distinguished Scholar Douglas Fearon, M.D., a professor at Cold Spring Harbor Laboratory (CSHL), has discovered how pancreatic...
The Lustgarten Foundation announced today the appointment of two new board members – Dr. Kenneth Goodman and Ms. Willa Shalit – to its current...
The Lustgarten Foundation announced today the appointment of David Tuveson, M.D., Ph.D., as its Chief Scientist. Dr. Tuveson is the Director of the...
South Florida residents are rallying together in the fight against pancreatic cancer in Boca Raton. On Sunday, February 25th, co-walk leaders Neal...
The Lustgarten Foundation announced today that it funded $22 million in 2017 as part of its commitment to invest an unprecedented $40 million by the...
The Lustgarten Foundation announced today that it received nearly $4 million from Creative Bath Products, Inc. to support pancreatic cancer research. ...
Today the Lustgarten Foundation for Pancreatic Cancer Research in partnership with Let's Win, an initiative supported by the Foundation, and Inspire...
The Lustgarten Foundation and Stand Up To Cancer (SU2C) announced today the launch of two new pancreatic cancer interception research projects – one...
A study published the week of September 4th in Proceedings of the National Academy of Science shows how combining mutations in circulating tumor DNA...
Lustgarten Foundation funded research discovered a mechanism of metastasis in pancreatic cancer, and perhaps, other cancer types as well. The...
The Lustgarten Foundation announced today that it will commit an unprecedented $40 million in 2017-18 through its new Translational Clinical Program, ...
In an unprecedented, fast-tracked review, the Food and Drug Administration (FDA) approved the use of pembrolizumab (anti-PDI) immunotherapy for...
By closely studying a part of the human genome that has not yet been carefully looked at before in pancreatic cancer cells, researchers supported by...
Lustgarten Foundation's funded research found that spatial distribution of cytotoxic T-cells in proximity to pancreatic ductal adenocarcinoma (PDAC)...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.